RAC1P1

Across TCGA pan-cancer cohorts, RAC1P1 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RAC1P1 data layer.

The strongest signal is observed in thymoma (THYM), where higher RAC1P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAC1P1 expression acts as an unfavorable survival marker.

THYM, HNSC, and PCPG are the cancer types where RAC1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.169	0.879	<.001	108	view →
HNSC	OS	Tertile	All	0.391	0.672	<.001	108	view →
PCPG	DFS	Tertile	All	0.381	0.931	<.001	27	view →
BLCA	DFS	Tertile	All	0.388	0.633	.013	18	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
STAD	OS	Tertile	II,III,IV	0.471	0.595	.031	12	view →
THCA	OS	Tertile	IV	0.520	0.840	.020	12	view →
GBM	OS	Tertile	All	0.089	0.415	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RAC1P1–THYM (OS)

Open the THYM breakdown →